J7637 Dexamethasone Inhalation | HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS J7637: Dexamethasone Inhalation Solution, Compounded, per mg

HCPCS Level II code J7637 represents a compounded, concentrated form of dexamethasone formulated for inhalation and billed per milligram when administered through durable medical equipment. The code is nationally relevant for facilities and providers that supply inhaled corticosteroid therapy via nebulizers or other DME, as it specifies a compounded drug product distinct from standard commercially available inhaled medications.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for inhaled dexamethasone delivered through DME, typical sites of service, and the billing implications of using a per-milligram compound code. The publication outlines common modifiers encountered in practice and highlights where data was not provided.

The piece explains what constitutes billing under J7637, why a compounded inhalation product may be billed separately from device or supply charges, and how this code fits into drug administration service lines. It also summarizes what to expect in benchmarking and policy review sections: coverage considerations across major payers, potential documentation needs, and areas where fee schedule or payment policy updates could affect billing. Data not available in the input is clearly noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ7637HCPCS Level IIinhalation therapydexamethasonedurable medical equipmentcompounded medicationsdrug administrationnebulizer

Billing Code Overview

HCPCS Level II code J7637 denotes dexamethasone, inhalation solution, compounded product, administered through DME, concentrated form, per milligram. This code describes a compounded inhalation formulation of dexamethasone intended for aerosolized delivery via durable medical equipment devices such as nebulizers. Service type: drug administration via durable medical equipment (inhalation therapy). Typical site of service: outpatient settings where DME is used, including home health or clinic-based nebulizer administration.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 7-year-old child with persistent asthma presents to a pediatric pulmonology clinic for management of acute exacerbations unresponsive to standard inhaled beta-agonist therapy. The clinician determines that an inhaled corticosteroid delivered via a nebulizer is required and prescribes a compounded concentrated inhalation solution of dexamethasone to be administered through durable medical equipment (nebulizer). The pharmacy compounds J7637 as a per-milligram concentrated solution and dispenses it with instructions for administration at home via the patient’s nebulizer. Clinical workflow:

Referral or visit documents indication, dose in mg, route (inhalation via nebulizer), and duration.
Prescribing clinician sends a written or electronic prescription specifying the compounded formulation and required quantity in milligrams.
Specialty or compounding pharmacy prepares the sterile or non-sterile inhalation solution, labels concentration, and packages with administration instructions.
Durable medical equipment supplier or pharmacy coordinates delivery of the solution and verifies patient training for nebulizer use.
Follow-up visit or telehealth encounter documents response, adverse effects, and any adjustments to therapy.

Coding Specifications

Modifier	Description

HCPCS J1412: Valoctocogene Roxaparvovec Gene Therapy Injection

HCPCS-J1833-ISAVUCONAZONIUM-INJECTION-1MG

HCPCS J1833: Injection, Isavuconazonium, 1 mg

HCPCS-J3472-HYALURONIDASE-OVINE-INJECTION-1000-UNITS

HCPCS Level II J3472: Injection, Hyaluronidase Ovine, Preservative Free

HCPCS-J2280-MOXIFLOXACIN-INJECTION-100MG

HCPCS J2280: Injection, Moxifloxacin 100 mg

HCPCS-J1265-DOPAMINE-40MG-INJECTION

HCPCS J1265: Injection, Dopamine HCl 40 mg

HCPCS-J7175-INJECTION-HUMAN-FACTOR-X-REPLACEMENT

HCPCS J7175: Injection, Human Factor X, 1 IU

HCPCS-J7030-INFUSION-NORMAL-SALINE-1000CC

HCPCS J7030: Infusion of Normal Saline Solution, 1000 cc

HCPCS-J1120-ACETAZOLAMIDE-INJECTION-500MG

HCPCS Level II J1120: Injection, Acetazolamide Sodium, up to 500 mg

HCPCS-J2320-NANDROLONE-DECANOATE-INJECTION-50MG

HCPCS J2320: Nandrolone Decanoate Injection, up to 50 mg

HCPCS-J1163-DILTIAZEM-INJECTION-0-5-MG

HCPCS J1163: Injection, diltiazem hydrochloride, 0.5 mg

Showing 1–10 of 991

Taxonomy Code	Specialty	Notes
`207RC0000X`	Pulmonology	Most common specialty prescribing inhaled corticosteroid solutions for respiratory disease.
`208000000X`	Pediatrics	Pediatricians or pediatric pulmonologists frequently manage pediatric asthma requiring nebulized steroids.
`363A00000X`	Pharmacy	Compounding pharmacists prepare the concentrated inhalation solution and handle dispensing.
`163W00000X`	Allergy & Immunology	Allergy specialists managing severe asthma or steroid-responsive airway disease may prescribe this therapy.
`207L00000X`	Critical Care Medicine	Intensivists may order nebulized dexamethasone formulations in hospitalized respiratory compromise cases.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J45.40`	Moderate persistent asthma, uncomplicated	Common indication for nebulized corticosteroid therapy when inhaler delivery is not adequate.
`J45.901`	Unspecified asthma with (acute) exacerbation	Nebulized dexamethasone may be used as part of management for acute exacerbations requiring concentrated inhalation therapy.
`J96.00`	Acute respiratory failure, unspecified whether with hypoxia or hypercapnia	In hospitalized patients, inhaled corticosteroids can be adjunctive therapy; compounding and DME administration may be documented.
`J98.01`	Acute bronchospasm	Nebulized corticosteroids or adjunctive therapies administered via DME can be used in bronchospasm management.
`R06.02`	Shortness of breath	Symptom code that supports medical necessity for inhaled respiratory treatments when other specific respiratory diagnoses are present.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`94640`	Pressurized or non-pressurized inhalation treatment for acute airway obstruction or for sputum induction for diagnostic purposes (e.g., nebulizer, metered dose inhaler, or IPPB device).	Often performed when delivering nebulized medications including compounded inhalation solutions; documents the respiratory therapy visit and medication administration.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes.	Commonly used for follow-up or management visits where the prescription for `J7637` is issued or reviewed.
`99406`	Smoking and tobacco use cessation counseling, intermediate, greater than 3 minutes up to 10 minutes.	May be provided concurrently for patients with smoke-related exacerbations; supports comprehensive asthma management.
`99070`	Supplies and materials (except spectacles), provided by the physician over and above those usually included with the office visit or procedure.	Used when billing for additional supplies related to nebulizer administration not included in standard DME or drug billing.
`94620`	Pulmonary stress testing or bronchospasm evaluation procedures (spirometry)	Performed before or after inhaled therapy to document airflow obstruction and response to therapy.

`00`	No modifier — standard reporting	Use when no additional modifier applies for the service.
`22`	Increased procedural services	Use if preparation required substantially greater work or complexity than typical compounding.
`23`	Unusual anesthesia	Not commonly used for inhalation solutions; include only if unusual local or monitored anesthesia was required during administration.
`52`	Reduced services	Use if a partially completed or reduced quantity of the compounded product was supplied.
`53`	Discontinued procedure	Use if compounding or delivery was started but later discontinued for clinical reasons.
`54`	Surgical care only	Generally not applicable; do not append unless service pertains strictly to surgical portion by one provider.
`55`	Postoperative management only	Generally not applicable to this DME drug; use if only post-procedural management is billed by a second provider.
`56`	Preoperative management only	Rare for this service; use only if preoperative care is separately billed.
`62`	Two surgeons	Not typically applicable; use only if two qualified providers share responsibility for a related procedure.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist billing for anesthesia	Only use if anesthesia services tied to administration are billed by an advanced practitioner.
`QX`	Modifier indicating services furnished by a CRNA with surgeon direction	Use only if a certified registered nurse anesthetist is furnishing associated anesthesia services.
`QY`	Medical direction of one CRNA by an anesthesiologist	Use only when applicable to anesthesia components of care.
`SH`	Diagnostic supply/SMB-modifier for DMEPOS	Use when supply is associated with a specific home health or DME program requiring this modifier.
`SJ`	Service furnished under a State, county or local government program	Use when a government program requires distinct billing identification for the compounded product.

OpenPayer